These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Identification of amino acid residues 300-315 of the rat FSH receptor as a hormone binding domain: evidence for its interaction with specific regions of FSH beta-subunit.
    Author: Leng N, Dattatreyamurty B, Reichert LE.
    Journal: Biochem Biophys Res Commun; 1995 May 16; 210(2):392-9. PubMed ID: 7755615.
    Abstract:
    We previously reported that residues 9-30 of the extracellular N-terminus domain of the rat FSH receptor, which has no homologous sequence in receptors for related pituitary glycoprotein hormones, represented a specific FSH binding domain. Further examination of its deduced primary structure identified another region, residues 300-315, which was also unique to the FSH receptor. To determine whether this region of the FSH receptor was involved in hormone binding, a synthetic peptide corresponding to residues 300-315 was studied with respect to its ability to bind FSH, as well as a series of nine overlapping synthetic peptides corresponding to the entire primary structure of the hormone specific FSH beta-subunit. 125I-FSH rec-(300-315) peptide bound to immobilized human, ovine and bovine FSH, but not to prolactin or ovalbumin. Of the nine synthetic peptides studied, binding was restricted to FSH beta residues 21-35, and to a much lesser extent (20%) to residues 11-25. All binding was abolished in the presence of excess solubilized FSH receptor. Earlier studies indicated that although FSH binds to FSH rec(9-30) peptide, residues 11-25 or 21-35 of the FSH beta-subunit were not involved. Our results suggest the FSH receptor N-terminus, extracellular residues 300-315, may define a FSH binding site, and that binding of FSH beta-subunit may occur via interactions with FSH beta 21-35 and 11-25.
    [Abstract] [Full Text] [Related] [New Search]